Navigation Links
WaferGen Announces Delay in Reporting of Second Quarter 2011 Results
Date:8/23/2011

FREMONT, Calif., Aug. 23, 2011 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTCBB:WGBS), a leading developer of state-of-the-art genomic analysis systems, announced today that it intends to file its Quarterly Report on Form 10-Q for the period ended June 30, 2011 within two weeks.  The company had previously filed a Form 12b-25 with the Securities and Exchange Commission relating to its Form 10-Q filing.  

In order to complete its financial statements and other information contained in the Quarterly Report on Form 10-Q, the company needs additional time to finalize the valuation amounts and related accounting treatment of convertible preferred stock, convertible notes and warrants issued on May 27, 2011 in the company's $30.6 million private placement financing.  

About WaferGen Biosystems, Inc. 

WaferGen Biosystems, Inc. develops, manufactures and sells state-of-the-art systems for genomic analysis for the life science and pharmaceutical industries to advance next generation sequencing and ultimately personalized medicine.  WaferGen offers the breakthrough SmartChip Real-Time PCR System, a next-generation Real-Time PCR system for discovery and validation of gene expression patterns (biomarkers) on a single platform. For additional information, please see http://www.wafergen.com.

Forward Looking Statements

This press release contains certain "forward-looking statements" relating to the expected filing date of the company's Form 10-Q for the second quarter of 2011.  Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the control of the company.  Actual results may differ materially from the expectations contained in the forward-looking statements.   More detailed information about t
'/>"/>

SOURCE WaferGen Biosystems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. WaferGen Announces Second Quarter 2008 Financial Results
2. WaferGen to Present at the Seventh Annual BIO Investor Forum
3. NIH Awards Approximately $3M Grant for Research Involving WaferGens SmartChip(TM) Real-Time PCR System at the University of Pittsburgh
4. WaferGen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
5. WaferGen Announces Third Quarter 2008 Financial Results
6. WaferGens SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program
7. Data on WaferGens SmartChip Real-Time PCR System(TM) to be Presented at 16th International Molecular Medicine Tri-Conference
8. Data on WaferGens SmartChip(TM) System Presented at 16th International Molecular Medicine Tri-Conference
9. WaferGen to Present Data on SmartChip(TM) Real-Time PCR System at Cambridge Healthtech Institutes Quantitative PCR Conference
10. WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound Healing Research
11. WaferGen Announces Signing of Private Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... (PRWEB) May 22, 2013 Oven Industries ... with the integrated potentiometers or via a PC through ... measuring two and one half inches square can deliver ... zero voltage switched, low noise solid state relay. Operator ... isolation for the communication port and sensor input. ...
(Date:5/22/2013)... iLuv Creative Technology, the premier provider ... mobile lifestyle, announces they are now shipping MultiCharger-X, an ... iPad devices efficiently. Winner of the 2013 internationally recognized ... award, MultiCharger-X is revolutionizing the way businesses, schools, and ... , MultiCharger-X (iAD910) combines the best ...
(Date:5/22/2013)... 2013 The Conference Forum ... to Advance Clinical Trials conference taking place on September ... MA. , Disruptive thinkers from Novartis, Pfizer, Eli ... bold approaches to reduce expensive infrastructure, engage patients and ... to be big, or novel, or it must change ...
(Date:5/22/2013)... May 22, 2013  Empire Genomics announced today ... patent pending novel genomic biomarker from Cornell University ... that could help in diagnosing and determining treatment ... Neuroendocrine prostate cancer (NEPC) is a ... arise de novo, but more commonly arises after ...
Breaking Biology Technology:New AC Temperature Controller Announced by Oven Industries 2iLuv Now Shipping the All New MultiCharger-X 2iLuv Now Shipping the All New MultiCharger-X 3Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer 2
... Nov. 20 Wyeth (NYSE: WYE ... been promoted to President,Technical Operations & Product Supply ... aspects of technical operations and product supply for,Wyeth, ... units. He succeeds Charles Portwood, 58, who ...
... meeting of the Board,of Directors of Wyeth (NYSE: ... share on the outstanding shares of Preferred Stock was declared,payable ... close of business,on December 12, 2008. , ... research-driven pharmaceutical and,health care products companies. It is a ...
... Inc.,(Nasdaq: HOLX ), a leading developer, manufacturer ... products dedicated to,serving the healthcare needs of women, today ... the investment community who will be attending the RSNA,(Radiological ... This meeting will ...
Cached Biology Technology:Wyeth Names Michael Kamarck President, Technical Operations & Product Supply 2Hologic, Inc. to Host Investor Reception at the RSNA Trade Show 2
(Date:5/21/2013)... concept of "place" is increasingly being considered in ... have a new resource that can help them ... with the places in their lives. , ... new book co-edited by the Pacific Northwest Research ... human-centered approach to conservation. The book is published ...
(Date:5/21/2013)... have found that a class of pharmaceuticals can both ... The drugs, known as "TSPO ligands," are currently used ... the effects of TSPO ligand in young adult mice ... aged mice when pathology was quite severe," said lead ... Gerontology. "TSPO ligand reduced measures of pathology and improved ...
(Date:5/21/2013)... University of Michigan Water Center today awarded 12 ... Lakes restoration and protection efforts. , The two-year ... projects, including efforts to track the remediation of ... to control non-native weedy plant invasions; study chromosomal ... responses to restoration activities. , The grants were ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4
... more allergies one has, the lower the risk of ... in Cancer Epidemiology, Biomarkers & Prevention , a ... Researchers from the University of Illinois at Chicago, used ... for 419 patents with glioma and 612 cancer-free patients ...
... gibbons (genus Nomascus ) live in dense Asian rainforest, ... their environment, they communicate with other gibbons by singing. Both ... find a mate, and couples also sing duets to strengthen ... access journal BMC Evolutionary Biology describes how gibbon ...
... An international team of researchers has made new links between ... common form of inflammatory bowel disease (IBD). The new findings ... associated with inflammatory bowel disease to 99. The results ... bodies maintain the lining of the intestinal wall, which are ...
Cached Biology News:Allergies lower risk of low- and high-grade glioma 2Research links 29 genome regions with common form of inflammatory bowel disease 2Research links 29 genome regions with common form of inflammatory bowel disease 3
... AvoidanceIncludes all features of Tracker, plus software to ... defined subsection of the arena, and trigger a ... instruments all built around a video camera, frame ... track two fields at once and up to ...
... ACS Reagent Grade C 19 H 9 ... 691.95 PRODUCT SPECIFICATIONS Form: Powder Clarity of ... pH 3.0 - Yellow pH 4.6 ... dye in agarose and acrylamide gel electrophoresis. ...
... innovation from Magnetofection technology, SilenceMag is ... available. Simple, rapid and easy to ... non toxic. Specifically designed for siRNA ... at very low doses of siRNA.,SilenceMag ...
... Software reads and processes raw ... microarray data for analysis. ... one 1-year license for Feature ... ,one CD-ROM containing Feature Extraction ...
Biology Products: